Headline Post

7 articles this week

Latest

SPAC IPO Terms Tracker: November 13, 2026

Terms Tracker for the Week Ending November 13, 2026 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week's pricings. Once again, there were no IPOs priced this week which keeps the year-to-date IPO count at 158, while total gross proceeds raised YTD ticks up slightly due to over-allotments to $30. More

Kristi Marvin·Nov 14

Morning SPAC News Roundup: November 13, 2026

SPACs have been relatively light on jumpy low float trading situations of late, but one new one may have just been created. Mountain Crest V (OTC:MCAG) held not one, but two votes this week to complete its business combination with VIANIQ as well as extend its transaction deadline to May 2027. More

Nicholas Alan Clayton·Nov 13

Top 3 SPAC Targets – Pharma Manufacturers

As discussed in the last iteration of this column focused on late-stage biotech firms, SPACs have increasingly turned to the drug development sector as a safe space on the board while various types of volatility have cropped up in the fourth quarter of 2026. More

Nicholas Alan Clayton·Nov 12

Podcast – The Robotaxi Pure-Play: Inside May Mobility’s $1.48 Billion SPAC Deal (ACGC)

This week, we speak with Edwin Olson, CEO and Co-founder of May Mobility, and Andrew Sung, President and CFO of ACP Holdings Acquisition Corp. (NASDAQ:ACGC) to discuss the $1.48 billion business combination they announced in September. More

Kristi Marvin·Nov 11

New SPACs: A Paradise III (APCD.U), ZA I (ZACAU), Research Alliance V (RACV) File for IPOs

A Paradise III Acquisition Corp. A Paradise III (NYSE:APCD.U) has filed for a $100 million IPO to potentially line up a second vehicle for a generalist search. The timing of this filing suggests that this serial sponsor wants to increase the pace of its dealmaking considering that it has A Paradise II (NYSE:APBD. More

Nicholas Alan Clayton·Nov 10

Morning SPAC News Roundup: November 10, 2026

A reading of fresh CPI inflation figures is on the docket followed by a full day of comments by Fed officials. Futures are hopeful on the Dow side for these events, but the Nasdaq has continued to sag as it is down about -9. More

Nicholas Alan Clayton·Nov 10

Globa Terra (GTERA) to Combine with Nature’s Ledger in $324M Deal

Globa Terra (NASDAQ:GTERA) has entered into a definitive agreement to combine with sustainability firm Nature’s Ledger at a $323.8 million pre-money equity value. Nature's Ledger places real world ecological assets on the blockchain to allow investors to trade carbon credits based on their preservation or improvement. More

Nicholas Alan Clayton·Nov 9

SPAC IPO Terms Tracker: November 6, 2026

Terms Tracker for the Week Ending November 6, 2026 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week's pricings. There were no IPOs priced this week, so the November monthly IPO count starts at zero, but deal announcements did the heavy lifting with five business combinations announced. More

Kristi Marvin·Nov 7

New SPACs: Churchill Capital XIV (CXIVU), Kartoon Studios (KACQ.U) File for IPOs

Churchill Capital Corp. XIV Churchill XIV has filed for a $300 million SPAC that would give the high-profile team a third vehicle out searching for a deal. The new SPAC is offering investors 1/10 warrants in its units, which is the same structure the team has gone with for the last three SPACs it has filed and IPO'd over the past year. More

Nicholas Alan Clayton·Nov 6

Armada III (AACI) to Combine with Brains Bioceutical in $892M Deal

Armada III (NASDAQ:AACI) has entered into a definitive agreement to combine with drug developer Brains Bioceutical at a pro forma enterprise value of $891.8 million. Brains Bioceutical has built out the manufacturing base to provide medical-grade cannabinoid ingredients to the biotech and consumer industries while pursuing its own potential drug candidates. More

Nicholas Alan Clayton·Nov 6